Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
about
New insights into the impact of neuro-inflammation in rheumatoid arthritisHow Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and VirusesIs rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis.Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis.Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy.Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.Anti-Infectious Human Vaccination in Historical Perspective.Characteristics of rheumatoid arthritis patients undergoing reverse shoulder arthroplasty.Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic disease.Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China.Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis.Identifying risk factors associated with infection in patients with chronic leg ulcers.Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice.
P2860
Q27023946-804E7054-B425-4E78-86FF-558698870F57Q27468876-95B5B34C-2CA8-4D54-9F76-E0012E263929Q36367842-41294B07-7F33-40B2-A294-8A0521A9E0EBQ37139101-3EB67AA2-7C1A-4F65-BC4A-F22C801FDF5CQ38404761-0BBC14D6-D97A-4D1C-98FF-CBC0F6C435FAQ38611360-4AF7654F-D089-4EA0-AF54-09FC6F26A63EQ38911873-931D0633-675B-4C55-B145-9C46DDABD666Q39829013-E5A284CE-5B86-4D5C-AF75-0A37F9F31487Q40129444-6DFBDF65-CB93-446F-97A4-4F7758ABE059Q40199980-499E0AA5-13A3-40A0-8175-B5B3ADB5872BQ40326976-FBEC9B97-C350-4588-8A9B-FC54ED188AB8Q42633753-9FC46A4C-6C29-4224-B37C-FF1BF85EFCABQ47547409-C6170E0A-7332-4591-A2F9-ED1F1E791693Q47676343-983291AF-4D0C-4AA9-A859-6BB275D83C8BQ54243018-2A201D6B-D9FA-478E-B4EB-9E2AB0A732BB
P2860
Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@en
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@nl
type
label
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@en
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@nl
prefLabel
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@en
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@nl
P2093
P2860
P356
P1476
Infection risk in rheumatoid a ...... teroids and TNF-α antagonists.
@en
P2093
Aurora Tarantino
John Osborn
Maria Sofia Cattaruzza
Raffaele D'Amelio
Roberta Di Rosa
Simonetta Salemi
Valentina Germano
P2860
P2888
P356
10.1186/1479-5876-12-77
P577
2014-03-22T00:00:00Z
P5875
P6179
1031974523